JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.68% |
| 2 | Financials | 11.13% |
| 3 | Consumer Discretionary | 9.78% |
| 4 | Healthcare | 9.62% |
| 5 | Industrials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Matsons
MATX
$6.46B
| $2.07M | ﹤0.01% |
32,303
-9,534
| -23% | -$623K |
|
3627
CALL
Nutanix
NTNX
$18B
| $2.06M | ﹤0.01% |
54,000
| – | – |
|
3628
Amneal Pharmaceuticals
AMRX
$6.16B
| $2.06M | ﹤0.01% |
402,835
-21,267
| -5% | -$121K |
|
|
ALLK
3629
DELISTED
Allakos
ALLK
| $2.06M | ﹤0.01% |
24,125
-5,340
| -18% | -$533K |
|
3630
CALL
IQVIA
IQV
$39.1B
| $2.06M | ﹤0.01% |
8,500
| – | – |
|
|
3631
PUT
IQVIA
IQV
$39.1B
| $2.06M | ﹤0.01% |
8,500
| – | – |
|
3632
Willdan Group
WLDN
$1.32B
| $2.06M | ﹤0.01% |
54,714
+2,675
| +5% | +$103K |
|
|
IAS
3633
DELISTED
Integral Ad Science
IAS
| $2.06M | ﹤0.01% |
+100,000
| New | +$2.06M |
|
|
CPTK.U
3634
DELISTED
Crown PropTech Acquisitions Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CPTK.U
| $2.06M | ﹤0.01% |
207,191
-557,444
| -73% | -$5.54M |
|
3635
iShares Russell Top 200 ETF
IWL
$2.28B
| $2.06M | ﹤0.01% |
20,000
| – | – |
|
|
KE
3636
Kimball Electronics
KE
$622M
| $2.06M | ﹤0.01% |
94,528
-43,700
| -32% | -$984K |
|
3637
Red Robin
RRGB
$185M
| $2.05M | ﹤0.01% |
62,041
+6,411
| +12% | +$219K |
|
|
MRTX
3638
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.05M | ﹤0.01% |
+12,700
| New | +$2.04M |
|
3639
Tennant Co
TNC
$1.18B
| $2.05M | ﹤0.01% |
25,633
-12,697
| -33% | -$1.04M |
|
3640
Ingles Markets
IMKTA
$1.65B
| $2.05M | ﹤0.01% |
35,103
-366
| -1% | -$22.7K |
|
3641
RBB Bancorp
RBB
$463M
| $2.04M | ﹤0.01% |
84,420
-33,508
| -28% | -$750K |
|
3642
PUT
Honeywell
HON
$74.2B
| $2.04M | ﹤0.01% |
+9,867
| New | +$2.09M |
|
3643
National Grid
NGG
$81.6B
| $2.04M | ﹤0.01% |
36,023
-110,971
| -75% | -$6.31M |
|
3644
PUT
Workday
WDAY
$49.3B
| $2.03M | ﹤0.01% |
8,500
+3,300
| +63% | +$794K |
|
|
GBT
3645
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.03M | ﹤0.01% |
57,919
-690,704
| -92% | -$27M |
|
3646
Middlesex Water
MSEX
$1.1B
| $2.02M | ﹤0.01% |
24,764
-10,997
| -31% | -$910K |
|
3647
VanEck Emerging Markets High Yield Bond ETF
HYEM
$527M
| $2.02M | ﹤0.01% |
84,668
+56,323
| +199% | +$1.34M |
|
3648
CALL
PNC Financial Services
PNC
$102B
| $2.02M | ﹤0.01% |
+10,600
| New | +$1.99M |
|
3649
PUT
Exelon
EXC
$47.3B
| $2.02M | ﹤0.01% |
63,931
+35,190
| +122% | +$1.13M |
|
|
ROCC
3650
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $2.02M | ﹤0.01% |
85,631
-13,924
| -14% | -$254K |
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q2 2021, opening 694 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 694 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.